Current and emerging knowledge in COVID-19
COVID-19 has emerged as a pandemic leading to a global public health crisis of
unprecedented morbidity. A comprehensive insight into the imaging of COVID-19 has …
unprecedented morbidity. A comprehensive insight into the imaging of COVID-19 has …
[HTML][HTML] Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Abstract SARS-CoV-2 Delta and Omicron are globally relevant variants of concern. Although
individuals infected with Delta are at risk of developing severe lung disease, infection with …
individuals infected with Delta are at risk of developing severe lung disease, infection with …
Coronavirus disease 2019 disease severity in children infected with the omicron variant
AA Butt, SR Dargham, S Loka, RM Shaik… - Clinical Infectious …, 2022 - academic.oup.com
Abstract Short Summary Severe acute respiratory syndrome coronavirus 2 infection from the
Omicron variant in children/adolescents is less severe than infection from the Delta variant …
Omicron variant in children/adolescents is less severe than infection from the Delta variant …
Clinical manifestations of COVID‐19 breakthrough infections: A systematic review and meta‐analysis
To provide a comparative meta‐analysis and systematic review of the risk and clinical
outcomes of coronavirus 2019 (COVID‐19) infection between fully vaccinated and …
outcomes of coronavirus 2019 (COVID‐19) infection between fully vaccinated and …
[HTML][HTML] SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2
KM Littlefield, RO Watson, JM Schneider… - PLoS …, 2022 - journals.plos.org
As of January 2022, at least 60 million individuals are estimated to develop post-acute
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
[HTML][HTML] Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
Background The COVID-19 pandemic is caused by the betacoronavirus SARS-CoV-2. In
November 2021, the Omicron variant was discovered and immediately classified as a …
November 2021, the Omicron variant was discovered and immediately classified as a …
Chest CT findings in hospitalized patients with SARS-CoV-2: Delta versus Omicron variants
SH Yoon, JH Lee, BN Kim - Radiology, 2023 - pubs.rsna.org
Background CT manifestations of SARS-CoV-2 may differ among variants. Purpose To
compare the chest CT findings of SARS-CoV-2 between the Delta and Omicron variants …
compare the chest CT findings of SARS-CoV-2 between the Delta and Omicron variants …
[HTML][HTML] Maternal and perinatal outcomes following pre-Delta, Delta, and Omicron SARS-CoV-2 variants infection among unvaccinated pregnant women in France …
G Favre, E Maisonneuve, L Pomar, C Daire… - The Lancet Regional …, 2023 - thelancet.com
Background SARS-CoV-2 positive pregnant women are at higher risk of adverse outcomes,
but little evidence is available on how variants impact that risk. We aim to evaluate maternal …
but little evidence is available on how variants impact that risk. We aim to evaluate maternal …
[HTML][HTML] COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar
Background Understanding the disease severity associated with the Omicron variant of the
SARS-CoV-2 virus is important in determining appropriate management strategies at the …
SARS-CoV-2 virus is important in determining appropriate management strategies at the …
A glycosylated RBD protein induces enhanced neutralizing antibodies against Omicron and other variants with improved protection against SARS-CoV-2 infection
ABSTRACT SARS-CoV-2 has mutated frequently since its first emergence in 2019.
Numerous variants, including the currently emerging Omicron variant, have demonstrated …
Numerous variants, including the currently emerging Omicron variant, have demonstrated …